Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Feb 3;6(3):557-558.
doi: 10.1016/j.ekir.2021.01.017. eCollection 2021 Mar.

Targeting NaPi-IIb for Hyperphosphatemia in Chronic Kidney Disease Patients - The Dead End?

Mugurel Apetrii  1 , Adrian Covic  1
Affiliations
Editorial

Targeting NaPi-IIb for Hyperphosphatemia in Chronic Kidney Disease Patients - The Dead End?

Mugurel Apetrii et al. Kidney Int Rep. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Eddington H., Hoefield R., Sinha S. Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:2251–2257. - PMC - PubMed
    1. Komaba H., Fukagawa M. Phosphate-a poison for humans? Kidney Int. 2016;90:753–763. - PubMed
    1. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney Int Suppl. 2009:S1–S130. - PubMed
    1. Hilfiker H., Hattenhauer O., Traebert M. Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci U S A. 1998;95:14564–14569. - PMC - PubMed
    1. Maruyama S., Marbury T.C., Connaire J. NaPi-IIb inhibition for hyperphosphatemia in chronic kidney disease hemodialysis patients. Kidney Int Rep. 2021;6:675–684. - PMC - PubMed

LinkOut - more resources